ZIMMER BIOMET HOLDINGS, INC. (ZBH) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 1.20B USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 6.28B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 22.80B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $1.20B | $6.28B | (m) | (m) | $22.80B | (m) |
| 2026-03-31 | (m) | (m) | $1.18B | $6.30B | (m) | (m) | $22.72B | (m) |
| 2025-12-31 | (m) | (m) | $587.10M | $6.93B | (m) | (m) | $23.09B | (m) |
| 2025-09-30 | (m) | (m) | $600.00M | $7.51B | (m) | (m) | $23.49B | (m) |
| 2025-06-30 | (m) | (m) | $820.00M | $6.75B | (m) | (m) | $22.87B | (m) |
| 2025-03-31 | (m) | (m) | $600.00M | $6.58B | (m) | (m) | $22.18B | (m) |
| 2024-12-31 | (m) | (m) | $863.00M | $5.34B | (m) | (m) | $21.37B | (m) |
| 2024-09-30 | (m) | (m) | $1.71B | $4.74B | (m) | (m) | $21.72B | (m) |
| 2024-06-30 | (m) | (m) | $1.88B | $3.96B | (m) | (m) | $21.52B | (m) |
| 2024-03-31 | (m) | (m) | $970.00M | $4.83B | (m) | (m) | $21.45B | (m) |
| 2023-12-31 | (m) | (m) | $900.00M | $4.87B | (m) | (m) | $21.50B | (m) |
| 2023-09-30 | (m) | (m) | $355.00M | $5.13B | (m) | (m) | $21.22B | (m) |
| 2023-06-30 | (m) | (m) | $520.00M | $5.19B | (m) | (m) | $21.29B | (m) |
| 2023-03-31 | (m) | (m) | $585.00M | $5.20B | (m) | (m) | $21.24B | (m) |
| 2022-12-31 | (m) | (m) | $544.30M | $5.15B | (m) | (m) | $21.07B | (m) |
| 2022-09-30 | (m) | (m) | $659.10M | $5.06B | (m) | (m) | $21.33B | (m) |
| 2022-06-30 | (m) | (m) | $851.90M | $5.17B | (m) | (m) | $21.45B | (m) |
| 2022-03-31 | (m) | (m) | $1.01B | $5.29B | (m) | (m) | $21.62B | (m) |
| 2021-12-31 | (m) | (m) | $1.61B | $5.46B | (m) | (m) | $23.46B | (m) |
| 2021-09-30 | (m) | (m) | $1.05B | $6.46B | (m) | (m) | $24.01B | (m) |
| 2021-06-30 | (m) | (m) | $1.05B | $6.80B | (m) | (m) | $24.22B | (m) |
| 2021-03-31 | (m) | (m) | $300.00M | $7.54B | (m) | (m) | $24.03B | (m) |
| 2020-12-31 | (m) | (m) | $500.00M | $7.63B | (m) | (m) | $24.42B | (m) |
| 2020-09-30 | (m) | (m) | $450.00M | $7.84B | (m) | (m) | $24.03B | (m) |
| 2020-06-30 | (m) | (m) | $450.00M | $7.76B | (m) | (m) | $23.65B | (m) |
| 2020-03-31 | (m) | (m) | $1.95B | $7.72B | (m) | (m) | $25.51B | (m) |
| 2019-12-31 | (m) | (m) | $1.50B | $6.72B | (m) | (m) | $24.64B | (m) |
| 2019-09-30 | (m) | (m) | $2.00B | $6.35B | (m) | (m) | $24.32B | (m) |
| 2019-06-30 | (m) | (m) | $2.00B | $6.72B | (m) | (m) | $24.21B | (m) |
| 2019-03-31 | (m) | (m) | $500.00M | $8.31B | (m) | (m) | $24.29B | (m) |
| 2018-12-31 | (m) | (m) | $525.00M | $8.41B | (m) | (m) | $24.13B | (m) |
| 2018-09-30 | (m) | (m) | $600.00M | $8.60B | (m) | (m) | $25.38B | (m) |
| 2018-06-30 | (m) | (m) | $100.00M | $9.41B | (m) | (m) | $25.49B | (m) |
| 2018-03-31 | (m) | (m) | $1.63B | $9.49B | (m) | (m) | $27.18B | (m) |
| 2017-12-31 | (m) | (m) | $1.23B | $8.92B | (m) | (m) | $25.96B | (m) |
| 2017-09-30 | (m) | (m) | $1.23B | $9.20B | (m) | (m) | $26.42B | (m) |
| 2017-06-30 | (m) | (m) | $1.33B | $9.35B | (m) | (m) | $26.46B | (m) |
| 2017-03-31 | (m) | (m) | $975.00M | $10.54B | (m) | (m) | $26.99B | (m) |
| 2016-12-31 | (m) | (m) | $575.60M | $10.67B | (m) | (m) | $26.68B | (m) |
| 2016-09-30 | (m) | (m) | $575.80M | $11.01B | (m) | $488.70M | $27.04B | (m) |
| 2016-06-30 | (m) | (m) | $500.00M | $10.53B | (m) | (m) | $25.97B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $11.12B | (m) | $1.01B | $26.30B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $11.56B | (m) | $1.62B | $27.22B | (m) |
| 2015-09-30 | (m) | (m) | $225.00M | $11.69B | (m) | $1.81B | $26.69B | (m) |
| 2015-06-30 | (m) | (m) | $300.00M | $11.75B | (m) | $1.88B | $27.20B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $9.06B | (m) | $9.28B | $17.19B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $1.43B | (m) | $1.70B | $9.63B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $1.43B | (m) | $1.75B | $9.67B | (m) |
| 2014-06-30 | (m) | (m) | (m) | $1.69B | (m) | $1.70B | $9.64B | (m) |
| 2014-03-31 | (m) | (m) | (m) | $1.68B | (m) | $1.59B | $9.38B | (m) |
| 2013-12-31 | (m) | (m) | (m) | $1.67B | (m) | $1.81B | $9.58B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $1.69B | (m) | $1.51B | $9.36B | (m) |
| 2013-06-30 | (m) | (m) | (m) | $1.69B | (m) | $1.24B | $9.10B | (m) |
| 2013-03-31 | (m) | (m) | (m) | $1.70B | (m) | $1.20B | $8.74B | (m) |
| 2012-12-31 | (m) | (m) | (m) | $1.72B | (m) | $1.56B | $9.01B | (m) |
| 2012-09-30 | (m) | (m) | (m) | $1.73B | (m) | $1.49B | $8.78B | (m) |
| 2012-06-30 | (m) | (m) | (m) | $1.73B | (m) | $1.34B | $8.62B | (m) |
| 2012-03-31 | (m) | (m) | (m) | $1.57B | (m) | $1.23B | $8.60B | (m) |
| 2011-12-31 | (m) | (m) | (m) | $1.58B | (m) | $1.22B | $8.52B | (m) |
| 2011-09-30 | (m) | (m) | (m) | $1.54B | (m) | $977.90M | $8.20B | (m) |
| 2011-06-30 | (m) | (m) | (m) | $1.15B | (m) | $945.50M | $8.25B | (m) |
| 2011-03-31 | (m) | (m) | (m) | $1.14B | (m) | $866.20M | $8.12B | (m) |
| 2010-12-31 | (m) | (m) | (m) | $1.14B | (m) | $934.00M | $8.00B | (m) |
| 2010-09-30 | (m) | (m) | (m) | $1.14B | (m) | $981.60M | $8.00B | (m) |
| 2010-06-30 | (m) | (m) | (m) | $1.13B | (m) | (m) | $7.83B | (m) |
| 2010-03-31 | (m) | (m) | (m) | $1.13B | (m) | (m) | $7.82B | (m) |
| 2009-12-31 | (m) | (m) | (m) | $1.13B | (m) | (m) | $7.79B | (m) |
| 2008-12-31 | (m) | (m) | (m) | $460.10M | (m) | (m) | $7.24B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |